Epidemiological Risk Factors and Perinatal Outcomes of Congenital Anomalies by Garcia Almeida, Lissa Fernandes et al.
Epidemiological Risk Factors and Perinatal
Outcomes of Congenital Anomalies
Fatores de risco epidemiológicos e resultados perinatais
das anomalias congênitas
Lissa Fernandes Garcia Almeida1 Edward Araujo Júnior2 Gerson Claudio Crott1
Marcos Masaru Okido1 Aderson Tadeu Berezowski1 Geraldo Duarte1 Alessandra Cristina Marcolin1
1Department of Gynecology and Obstetrics, Faculdade de Medicina
de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto,
São Paulo, Brazil
2Department of Obstetrics, Universidade Federal de São Paulo, São
Paulo, São Paulo, Brazil
Rev Bras Ginecol Obstet 2016;38:348–355.
Address for correspondence Edward Araujo Júnior, PhD, Rua
Napoleão de Barros, 875, Vila Clementino, 04024-002, São Paulo, SP,
Brazil (e-mail: araujojred@terra.com.br).
Keywords
► pregnancy
► congenital anomaly
► epidemiological risk
factor
► ultrasound
► perinatal outcome
Abstract Objectives To identify the epidemiological risk factors for congenital anomalies (CAs)
and the impact of these fetal malformations on the perinatal outcomes.
Methods This prospective cohort study comprised 275 women whose fetuses had
CAs. Maternal variables to establish potential risk factors for each group of CA and
perinatal outcomes were evaluated. The primary outcome was CA. Secondary out-
comes included: fetal growth restriction (FGR); fetal distress (FD); premature rupture of
membranes (PROM); oligohydramnios or polyhydramnios; preterm delivery (PTD);
stillbirth; cesarean section; low birth weight; Apgar score < 7 at the 1st and 5th
minutes; need for assisted ventilation at birth; neonatal infection; need for surgical
treatment; early neonatal death; and hospitalization time. Chi-square (2) test and
multilevel regression analysis were applied to compare the groups and determine the
effects of maternal characteristics on the incidence of CAs.
Results The general prevalence of CAs was of 2.4%. Several maternal characteristics
were associated to CAs, such as: age; skin color; level of education; parity; folic acid
supplementation; tobacco use; and history of previous miscarriage. There were no
significant differences among the CA groups in relation to FGR, FD, PROM, 1-minute
Apgar score > 7, and need for assisted ventilation at birth. On the other hand, the
prevalence of the other considered outcomes varied significantly among groups.
Preterm delivery was significantly more frequent in gastrointestinal tract/abdominal
wall defects. The stillbirth rate was increased in all CAs, mainly in isolated fetal hydrops
(odds ratio [OR]: 27.13; 95% confidence interval [95%CI]: 2.90–253.47). Hospitaliza-
tion time was higher for the urinary tract and congenital heart disease groups
(p < 0.01). Neonatal death was significantly less frequent in the central nervous
system anomalies group.
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Introduction
Congenital anomalies (CAs), fetal growth restriction and
prematurity are the main causes of morbidity and mortality
during childhood.1,2 The etiologies of many developmental
disorders are poorly understood; however, some risk factors
have already been identified, such as environmental or
occupational exposures,3 medications,4 smoking,5 the use
of illicit drugs6 and alcohol7; maternal diseases, such as
pregestational diabetes mellitus8 and thyroid dysfunction;9
and congenital infections.10,11
The European Surveillance of Congenital Anomalies (EURO-
CAT) recorded a total prevalence of major CAs of 23.9 per 1,000
births for 2003–2007.12According to this network, 80% of those
were livebirths, 2.0% were stillbirths or fetal deaths from
20 weeks gestation, and 17.6% of all cases were terminations
of pregnancy. Among the live births with CAs, 2.5% died during
the first week of life. Congenital heart defects were the most
commonCAineuploid fetuses, followedby limbdefects, urinary
tract malformations and central nervous system anomalies. A
better understanding of the possible risk factors associatedwith
CAs is crucial for the primary prevention, especially during the
preconceptional period.13 Furthermore, prenatal diagnosis of
CAs is important for adequate perinatal management in a
tertiary healthcare service with a multidisciplinary team to
decrease morbidity and mortality rates,14–16 mainly in coun-
tries where the termination of pregnancy is not allowed.17
The prenatal ultrasound accuracy to detect CAs ranges in
different countries (31–61%), which seems to be related to
the health public policy regarding the prenatal ultrasound
screening programs.18–20 Since CAs are highly prevalent and
associated with adverse perinatal outcomes, an adequate
prenatal diagnosis is imperative for an appropriate perinatal
management, allowing the reduction of perinatal morbidity
and mortality rates. Therefore, surveillance networks of CAs
able to point out weak points in prenatal screening policies
Conclusion It was possible to identify several risk factors for CAs. Adverse perinatal
outcomes were presented in all CA groups, and may differ according to the type of CA
considered.
Resumo Objetivos Identificar os fatores epidemiológicos de risco para anomalias congênitas
(ACs) e o impacto destas malformações fetais sobre os resultados perinatais.
Métodos Este estudo de coorte prospectivo compreendeu 275 mulheres cujos fetos
tinham ACs. Variáveis maternas para estabelecer potenciais fatores de risco para cada
grupo de AC e resultados perinatais foram avaliados. O desfecho primário foi CAs. Os
desfechos secundários incluíram: restrição de crescimento fetal (RCF); sofrimento fetal
(SF); ruptura prematura de membranas (RPM); oligo-hidrâmnio ou polidrâmnio; parto
pré-termo (PPT); morte fetal; parto cesárea; baixo peso ao nascer; índice de Apgar < 7
no 1° e 5° minutos; necessidade de ventilação assistida no momento do nascimento;
infecção neonatal; necessidade de tratamento cirúrgico; óbito neonatal precoce; e
tempo de internação. Teste de Qui-quadrado (2) e análise de regressãomúltipla foram
aplicados para comparar os resultados entre os grupos e determinar os efeitos das
características maternas sobre a incidência de ACs.
Resultados A prevalência geral de ACs foi de 2.4%. Várias características maternas
foram associadas às ACs, tais como: idade; cor da pele; escolaridade; paridade;
suplementação com ácido fólico; tabagismo; e histórico de aborto anterior. Não houve
diferenças significativas entre os grupos de ACs com relação à RCF, SF, RPM, índice de
Apgar < 7 no 1°minuto e necessidade de ventilação assistida no nascimento. Por outro
lado, a prevalência dos demais resultados adversos considerados variou significativa-
mente entre os grupos. O parto pré-termo foi significativamente mais frequente nos
casos de defeitos do trato gastrointestinal/parede abdominal. As taxas de óbito fetal
foram elevadas em todos os grupos de ACs, principalmente na hidropsia fetal isolada
(odds ratio [OR]: 27.13; intervalo de confiança de 95% [IC95%]: 2.90–253.47). O tempo
de internação foi maior nos casos de anomalias do trato urinário e nas cardiopatias
congênitas (p < 0,01). O óbito neonatal foi significativamente menos frequente no
grupo de anomalias do sistema nervoso central.
Conclusão Foi possível identificar vários fatores de risco para ACs. Resultados
perinatais adversos foram observados em todos os grupos de ACs, e podem diferir
de acordo com o tipo de AC considerada.
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could contribute for implementing the required improve-
ments and increase the detection rates of fetal
malformations.
Despite the fact that CAs are a highly reported topic in
scientific literature, very little information is available re-
garding the potential risk factors associated with these
anomalies and their perinatal outcomes. Thus, the objectives
of the present studywere to identify the epidemiological risk
factors for CAs and evaluate the impact of these fetal defects
on the perinatal outcome.
Methods
This prospective cohort study comprised 289 high-risk preg-
nant women whose fetuses had CAs. All participants were
recruited from the group of women admitted to the university
hospital of the Faculdade de Medicina de Ribeirão Preto, São
Paulo, Brazil, from September 2011 to July 2013. This 34-bed
unit is a Fetal Medicine reference center in Brazil covering an
area of 2 million inhabitants in the north of the State of São
Paulo. This tertiary healthcare service serves  1,800 high-risk
pregnant women per year within the Brazilian public health
system. The aimandmethodologyof the studywas explained to
all recruited women. Voluntary participation was requested,
and informed consent was obtained. This study was approved
by the local Ethics Research Committee (protocol number 6319/
2011) in agreement with the current procedures and according
to the internationally acknowledged Strengthening the Report-
ing of Observational Studies in Epidemiology (STROBE) criteria.
The inclusion criteria were: 1) pregnant women carrying
fetuses with CAs diagnosed at any trimester of pregnancy;
and 2) gestational age determined by the last menstrual period
and confirmed by ultrasound examperformed until 13thweek.
Following the exclusion of subjects throughout the study, data
from 275 pregnant women were used for the current analysis.
Fourteen subjects were excluded by the following reasons:
failure to follow-up (n ¼ 9) and inability to obtain all data
from medical records (n ¼ 5).
All recruited pregnant women were referred to our ser-
vice from primary or secondary public healthcare services
after an ultrasound level I demonstrating CAs. After admis-
sion to the institution, the pregnant women were submitted
to an ultrasound level III to properly diagnose the CA. All
scanswere transabdominal, using a 4–8 MHzprobe (Voluson
730 Expert, GE Medical Systems, Milwaukee, WI, USA) oper-
ated by experienced sonographers who had the appropriate
Fetal Medicine Certificate of Competence in the fetal anom-
aly assessment. During the prenatal follow-up, the pregnant
women had genetic counselling, psychological support, and
additional appointments with a multidisciplinary team
(neonatologists, pediatric surgeons, neurosurgeons, cardio-
vascular surgeons, and anesthesiologists). Termination of
pregnancy was not performed, since it is not allowed by
the country’s laws (except in the case of anencephaly).
Maternal demographic characteristics and ultrasonographic
findings were recorded in a computer database. Details
regarding pregnancy and neonatal outcomes were added
to the database as soon as they became available.
Definitions and Outcomes
For data analysis, CAs were divided into seven groups
according to type: 1) central nervous system (CNS); 2)
urinary tract (UT); 3) heart and great vessels (HGV); 4)
gastrointestinal tract/abdominal wall (GI); 5) musculoskele-
tal (ME); (6) isolated fetal hydrops; and 7) others. This latter
category comprised fetuses with multiple malformations,
congenital diaphragmatic hernia, and tumors.
The primary outcome was CA. The following maternal
variables were considered as potential risk factors for each
group of CA: age (< 19 years, 20–35 and > 35 years); skin color
(white or non-white); level of education ( 8 years, > 8 years);
professional activity (with or without); body mass index (nor-
mal, overweight or obese); smoking; use of medications with
teratogenic potential; regular folic acid supplementation;parity
(primigravida, secundigravida, multigravida); history of previ-
ous miscarriage; and chronic diseases.
Secondary outcomes included: fetal growth restriction
(estimated fetal weight < 10th percentile for the gestational
age);21 fetal distress followed by cesarean section; prema-
ture rupture of membranes; oligohydramnios or polyhy-
dramnios (single deepest pocket < 5th percentile
or > 95th for the gestational age);22 preterm delivery (birth
before 37 weeks of gestation); stillbirth (fetal death after
20 weeks of gestation); cesarean section; low birth weight
(below 2,500 g); Apgar score < 7 at the 1st and 5th minutes;
need for assisted ventilation at birth; neonatal infection;
need for surgical treatment; and early neonatal death.
Statistical Analysis
A sample size of 250 fetuses (subjects) was estimated based
on the prevalence of CAs of 1.5% in the general population,
and the detection rate of 3.0% in the high-risk population,
considering a significance level of 5% and power of 80%.
However, considering a 10% of failure to follow-up, a sample
size of 275 would be enough to perform this study.
Mean, standard deviation (SD), median, minimum and
maximum were used to describe the variable hospitalization
time. Percentages were used to describe qualitative variables.
The Chi-square (2) test was applied to verify the association
between the categorical variables and CAs. Simple and multi-
ple logistic regression analyses were used to determine the
effects of maternal characteristics on the incidence of CAs at
birth and the influence of types of CA on the perinatal out-
comes.23 The Kruskal-Wallis or Mann-Whitney tests were
applied toverify thedifferences in secondaryoutcomes among
CAgroups.All analyseswereperformedusing theSASsoftware
version 9.0 (Cary, North Carolina, USA). A p < 0.05 was con-
sidered statistically significant.
Results
The general prevalence of CAs was of 2.4%. The following
groups of birth defects were identified: CNS (n ¼ 78, 28.4%);
UT (n ¼ 59, 21.5%); HGV (n ¼ 32, 11.6%); GI (n ¼ 38, 13.8%);
ME (n ¼ 18, 6.6%); hydrops (n ¼ 15, 54%); and others
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(n ¼ 35, 12.7%). ►Table 1 shows the maternal demographic
variables taking into account different CA groups. We ob-
served a higher rate of pregnant womenwith higher levels of
education (> 8 years) in the HGV defects and hydrops groups
(p ¼ 0.041). Other maternal variables did not differ signifi-
cantly among the CA groups; however, some findings should
be highlighted. There were more teenagers in the GI and ME
groups. The proportions of women who used medications
were higher in the CNS and UT groups. Furthermore, we
noticed higher rates of pregnant women smokers in the GI
and ME groups. In addition, folic acid supplementation was
less common in the GI group; there was a higher rate of
multigravida in the HGV group, and a higher rate of women
with previous miscarriages in the hydrops group.
►Table 2 shows the concordance between the ultrasound
levels I III performed by aMaternal-Fetal Medicine specialist.
Table 1 Maternal demographic variables taking into account different groups of congenital anomalies
Type of congenital anomaly p
Central
nervous
system (%)
Urinary
tract (%)
Heart and
great
vessels (%)
Gastrointestinal/
abdominal
wall (%)
Musculoskeletal
(%)
Isolated
hydrops
(%)
Others
(%)
Maternal age
(mean  SD)
25.55  6.0 26.24  6.6 27.23  7.0 23.32  7.8 24.50  5.8 28.47  5.1 28.07  7.4
 19 years 14.1 18.6 12.5 28.9 27.8 0.0 8.6 NS
20–35 years 78.2 69.5 68.7 63.2 66.7 93.3 71.4
> 35 years 7.7 11.9 18.8 7.9 5.5 6.7 20.0
Skin color
White 88.5 79.7 75.0 76.3 72.2 86.7 77.1 NS
Non-white 11.5 20.3 25.0 23.7 27.8 13.3 22.9
Level of education
 8 years 44.9 61.0 34.4 60.5 55.6 26.7 40.0 0.041
> 8 years 55.1 39.0 65.6 39.5 44.4 73.3 60.0
Occupation
Without 53.8 67.8 43.7 65.8 72.2 40.0 51.4 NS
With 46.2 32.2 56.3 34.2 27.8 60.0 48.6
Chronic diseases
Yes 15.4 20.3 12.5 13.2 22.2 0.0 25.7 NS
No 84.6 79.7 87.5 86.8 77.8 100.0 74.3
Smoking
Yes 11.5 6.8 9.4 18.4 27.8 20.0 2.8 NS
No 88.5 93.2 90.6 81.6 72.2 80.0 97.2
Body mass index (kg/m2)
Normal 56.4 54.3 62.5 52.6 44.4 40.0 42.9 NS
Overweight 24.3 28.8 28.1 34.2 44.4 40.0 40.0
Obese 19.3 16.9 9.4 13.2 11.2 20.0 17.1
Medication use
Yes 14.1 8.5 9.4 10.5 5.6 6.7 14.3 NS
No 85.9 91.5 90.6 89.5 94.4 93.3 85.7
Folic acid supplementation
Yes 32.1 25.4 37.5 13.2 38.9 20.0 31.4 NS
No 67.9 74.6 62.5 86.8 61.1 80.0 68.6
Parity
Primigravida 46.2 35.6 31.2 42.1 38.9 33.3 37.1 NS
Secundigravida 28.2 28.8 21.9 23.7 22.2 46.7 31.4
Multigravida 25.6 35.6 48.9 34.2 38.9 20.0 31.5
Previous miscarriage
Yes 14.1 20.3 21.9 26.3 22.2 33.3 22.9 NS
No 85.9 79.7 78.1 73.7 77.8 66.7 77.1
Abbreviation: NS, non-significant; SD, standard deviation.
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The highest concordance occurred in the GI defect group
(84.2%), and the lowest concordancewas detected in theHGV
defect group (28.1%).
Multiple logistic regression analyses were applied to deter-
mine the effects of maternal parameters on the prevalence of a
specific type of CA. Non-white skin color decreased the risk of
CNS anomalies by nearly 60% (OR: 0.43; 95%CI: 0.19–0.97;
p ¼ 0.04). High levels of education decreased the risk of UT
defects by almost 50% (OR: 0.52; 95%CI: 0.29–0.94; p ¼ 0.03).
Primigravida showed a reduced risk of having a newborn with
HGVdefects (OR: 0.26; 95%CI: 0.08–0.80; p ¼ 0.02). In addition,
maternal age > 19years and regular folic acid supplementation
were associated with decreased risk of GI malformations by
nearly 60% (OR: 0.42; 95%CI: 0.19–0.95; p ¼ 0.04) and 65%
(OR: 0.34; 95%CI: 0.13–0.91; p ¼ 0.03) respectively. Smoking
increased the risk ofME anomalies by 3 times (OR: 3.28; 95%CI:
1.08–9.90; p ¼ 0.04). Furthermore, history of previous miscar-
riage increased the risk of hydrops by almost 8 times (OR: 7.65;
95%CI: 1.40–41.66; p ¼ 0.02).
►Table 3 shows the perinatal outcomes considering differ-
ent CA groups. The following perinatal complications were
associatedwith CAs: polyhydramnios; oligohydramnios; still-
birth; preterm delivery; cesarean section; low birth weight;
need for pressure support; neonatal infection; need for surgi-
cal treatment; and early neonatal death. Polyhydramnios was
more common in the ME and hydrops groups specifically,
with a prevalence of 38.9% (OR: 4.46; 95%CI: 1.09–18.29) and
40% (OR: 4.67; 95%CI: 1.07–20.32) respectively. On the other
hand, oligohydramnios was more common in the UT malfor-
mation group (OR: 12.55; 95%CI: 1.58–99.38). The prevalence
of stillbirth was high in all CA groups, mainly in the hydrops
(OR: 27.13; 95%CI: 2.90–253.47). Preterm delivery was very
common in all CA groups (18.7–86.7%), especially in the GI
defects (OR: 5.96; 95%CI: 1.99–17.84) and hydrops groups
(OR: 28.16; 95%CI: 4.98–159.38). The prevalence of low birth
weight was high in all CA groups, mainly in the GI defects
group (OR: 2.08; 95%CI: 1.08–27.83), theME anomalies group
(OR: 3.34; 95%CI: 1.34–38.52) and in the others group (OR:
Table 2 Concordance between the ultrasound scan performed by non-specialists (level I) and Maternal-Fetal Medicine specialists
(level III)
Type of congenital anomaly
Central
nervous
system
Urinary
tract
Heart and
great
vessels
Gastrointestinal/
abdominal wall
Musculoskeletal Isolated hydrops Others
Number of cases 78 59 32 38 18 17 35
Concordance (%) 70.5 59.3 28.1 84.2 38.9 66.7 68.6
Discordance (%) 29.5 40.7 71.9 15.8 61.1 33.3 31.4
Table 3 Perinatal outcomes considering different groups of congenital anomalies
Type of congenital anomaly p
Central
nervous
system
(%)
Urinary
tract
(%)
Heart and
great
vessels
(%)
Gastrointestinal/
abdominal
wall (%)
Musculoskeletal
(%)
Isolated
hydrops
(%)
Others
(%)
Fetal growth restriction 3.8 1.7 6.3 2.6 11.1 6.7 14.3 NS
Fetal distress 2.6 1.7 3.1 5.3 0 0 14.3 NS
Premature rupture of
membranes
10.3 11.9 3.1 18.4 22.2 20.0 17.1 NS
Polyhydramnios 10.3 5.1 12.5 13.2 38.9 40.0 20.0 < 0.01
Oligohydramnios 3.8 28.8 3.1 13.2 5.6 13.3 11.4 < 0.01
Fetal death 9.0 6.8 3.1 7.9 11.1 46.7 8.6 < 0.01
Preterm delivery 23.1 33.9 18.7 57.9 33.3 86.7 31.4 < 0.01
Cesarean section 75.6 39.0 81.3 84.2 72.2 46.7 60.0 < 0.01
Low birth weight 24.4 20.3 21.9 42.1 66.7 40.0 42.9 < 0.01
Apgar < 7 at the 1st minute 35.2 34.5 29.0 40.0 68.7 62.5 43.7 NS
Apgar < 7 at the 5th minute 12.7 27.3 6.5 20.0 37.5 50.0 21.9 0.02
Need for assisted ventilation 43.7 47.3 38.7 71.4 68.7 62.5 56.3 NS
Neonatal infection 19.7 10.9 48.4 48.6 25.0 12.5 21.9 < 0.01
Need for surgical treatment 54.9 27.3 61.3 91.4 25.0 37.5 25.0 < 0.01
Early neonatal death 12.7 25.5 41.9 37.1 62.5 50.0 28.1 < 0.01
Abbreviation: NS, non-significant.
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1.98; 95%CI: 1.05–7.25). Additionally, Apgar score < 7 at the
5th minute was high in all types of CA, especially in the UT
malformations group (OR: 5.44; 95%CI: 1.15–25.64), the ME
anomalies group (OR: 8.70; 95%CI: 1.51–50.28) and the
hydrops group (OR: 14.50; 95%CI: 1.98–106.44). Infections
were less prevalent in the CNS defects group (OR: 0.26; 95%CI:
0.11–0.65), as well as in the UT anomalies group (OR: 0.13;
95%CI: 0.04–0.39) and in the others group (OR: 0.30; 95%CI:
0.10–0.89). Surgeries were less necessary in the UT anomalies
group (OR: 0.24; 95%CI: 0.09–0.60), in theMEgroup (OR: 0.21;
95%CI: 0.06–0.81), and in the others group (OR: 0.21; 95%CI:
0.07–0.62). In contrast, it was more common in the GI group
(OR: 6.74; 95%CI: 1.68–26.96). Early neonatal death rate was
high in all CA groups; however, it was significantly
less common in the CNS defects group (OR: 0.20; 95%CI:
0.07–0.55).
►Table 4 shows the hospitalization time of all CA groups.
In general, the hospitalization time was higher in the sub-
groups of GI anomalies and HGV defects (p < 0.01). Hospi-
talization time was also higher in the subgroups in which
surgery was required or had neonatal infection. On the other
hand, hospitalization time was lower in the subgroups with
Apgar scores < 7 at the 5th minute, probably because of
their high mortality rate.
Discussion
In the present study, the prevalence of CAs was of 2.4%,
considering  10 thousand ultrasound scans performed at
our institution between 2011 and 2013. This rate is similar to
the one fromDolk et al,12who described the prevalence of CAs
in Europe. Central nervous system anomalies, including open
neural tube defects, were the most common CA detected in
fetuses, a finding similar to those reported on other studies.
The majority of the CAs of the fetal CNS is identified by the
second-trimester ultrasound at 20–24 weeks of gestation,
which makes them the most common.24 Furthermore, CNS
defect was a CA group with high concordance (71%) between
ultrasound scans performed by non-specialists (level I) and
Maternal-Fetal Medicine specialists (level III).
Urinary tract malformation constitutes  20% of all CAs,
which is coincident with the data presented here.18 Howev-
er, the concordance between the diagnoses made by sonog-
raphers with different levels of experience is lower than CNS
anomalies. A possible explanation for this result would be
that up to 80% of UT malformations can be solved spontane-
ously during fetal life, or worsened with advancing gesta-
tional age and impaired fetal renal function.25 Multicystic
dysplasia might not be identified in the second trimester
Table 4 Hospitalization time of live newborns according to the congenital anomaly group and their perinatal outcomes
Hospitalization time (days) p
n Mean Standard deviation Minimum Median Maximum
Congenital anomaly
Central nervous system 71 24.9 31.9 1.0 14.0 201.0
Heart and great vessels 31 28.3 35.5 1.0 12.0 130.0 < 0.01§
Gastrointestinal/ abdominal wall 35 34.5 36.2 1.0 26.0 160.0
Urinary tract 55 12.8 27.2 1.0 3.0 150.0
Isolated hydrops 8 9.9 12.6 1.0 5.0 36.0
Musculoskeletal 16 20.9 42.4 1.0 4.0 152.0
Others 32 24.8 51.1 1.0 9.0 274.0
Early neonatal death
No 176 28.0 37.5 1.0 14.0 274.0 < 0.01
R
Yes 72 11.6 27.9 1.0 1.0 160.0
Need for surgical treatment
No 128 10.1 26.5 1.0 4.0 274.0 < 0.01
R
Yes 120 37.3 38.9 1.0 24.0 201.0
Neonatal infection
No 184 14.3 23.7 1.0 6.0 150.0 < 0.01
R
Yes 64 49.0 49.7 1.0 33.5 274.0
Apgar score at the 5th minute
< 7 50 19.4 47.6 1.0 1.0 274.0 < 0.01
R
 7 198 24.2 32.1 1.0 12.0 201.0
Number of live newborns;
§Kruskal-Wallis test;R
Mann-Whitney test.
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scan; on the other hand, renal agenesis and lower urinary
tract obstruction can be identified early, while milder
obstructions are diagnosed later.26
In the present study, the prevalence of congenital heart
diseasewas of 11.6%, which is in agreement with thefindings
of studies conducted in tertiary reference centers. However,
the analysis of this CA group showed the lowest concordance
(28.1%) between ultrasound scans level I and III. This can be
explained by the difficulty of non-specialist sonographers in
achieving a proper examination of the fetal heart and great
vessels. It is well known that the detection rates of HGV
defects increase with the examiner’s ultrasound experience
and training, and with the adoption of a systematic ultra-
sound examination of the fetal heart.27,28
The prevalence of GI malformations was coincident with
the data presented in other studies (13.8%).29 Furthermore, GI
anomaly was the CA group with the highest concordance
(84%) between findings of ultrasound scans level I and III. The
most commonGImalformationswere abdominalwall defects,
which can be easily identified by ultrasound scan performed
after 13weeks of gestation. In addition, esophageal atresia and
small bowel obstructions are readily identified in the third
trimester due to the presence of polyhydramnios.
Because of themultifactorial etiology of CAs, we proposed
to assess the effect of maternal demographic factors on their
occurrence; however few factors showed to have a positive
correlation with CAs. This result is probably due to the small
sample size. Moreover, the appropriate process of gathering
and measuring information on targeted variables, such as
skin color, smoking, use of medications and folic acid sup-
plementation is not very reliable because of two main
reasons: the occurrence of a mixed population in our coun-
try, and the low socioeconomic status of our patients.
According to our data, parity was a maternal risk factor for
HGVdefects.Multigravidahave ahigher riskofhaving children
affected by this type of CA compared with primigravida or
secundigravida. This finding is similar to the Csermely et al30
study that assessed 21,494 fetuses with different isolated
malformations, and compared them to 34,311 normal con-
trols. The authors showed that multiparity was a significant
risk factor for the following five types of HGV anomalies:
ventricular septal defect; ostium secundum atrial septal de-
fect; persistence of arteriosus ductus; conotruncal cardiac
defect; and ventricular outflow tract obstructions.
Smoking was a risk factor for ME anomalies. Overall, the
prevalence of CAs does not seem to be increased among
children of womenwho smoked during pregnancy. However,
Morales-Suárez-Varela et al31 demonstrated that pregnant
womenwho did not smokebut used nicotine patches had the
riskof having childrenwithME anomalies (95%CI: 1.53–4.52)
increased by 2.6 times. The authors suggested that nicotine
can interfere with the mechanism of genomic "imprinting"
and lead to this type of CA. Another finding of the present
study was the history of previous miscarriage as a risk factor
for hydrops. It is well known that a large proportion of
miscarriages is caused by genetic abnormalities, and their
recurrence could be one of the causes of hydrops in the
current pregnancy.32
There were two variables that provided protection against
CAs. Maternal age > 19 years and folic acid supplementation
were associated with a decreased risk of GI malformations.
Eckmann-Scholzet al33 foundthat teenagershavean increased
risk of having newborns with GI malformations, especially
gastroschisis. This can be explained by the fact that pregnancy
during adolescence may be associated with several risk con-
ditions for CAs, such as use of illicit drugs, alcoholism, and
nutritional deficiencies.33Many studies point out to the effec-
tive prevention of fetal CAs with the regular folic acid supple-
mentation mainly open neural tube defects.12,34
Changes of amniotic volume fluid were more frequent in
fetuseswith skeletal dysplasia and isolatedhydrops. In skeletal
malformations, a small thorax causes increased intrathoracic
pressure and decreased fetal swallowing.32 In hydropic
fetuses, polyhydramnios may be a consequence of increased
urine production.32 In contrast, oligohydramnios was more
common in the UT group, in which urine production is
impaired by the existence of dysplastic kidneys or distal
obstructions of the UT.26
In the present study, fetal death rateswerehigh for all types
of CAs compared with the general population due to the
severity of malformations.35 In addition, preterm delivery
rates were very high mainly for the GI anomalies and hydrops
groups because of spontaneous labor caused by polyhydram-
nios or suspicion of ischemic bowel and compromised fetal
wellbeing respectively. As a consequence, theelective cesarean
section rateswere also increased for those reasons, and also to
obtain a successful perinatalmanagementofneonates through
delivery planning with a multi-professional team.
Neonatal adverse outcomes were extremely common in all
CA groups. Hospitalization time was increased for all of them
as a result of preterm delivery, low birth weight, Apgar score
< 7 at the 5thminute, neonatal infection, andneed for surgical
treatment. Neonatal death rates were significantly increased
in all CAgroups as a consequenceofall perinatal complications
previously described. The causes behind the low Apgar scores
may be listed as difficult fetal extraction at the cesarean
section or labor dystocia in skeletal dysplasia and hydrops;
respiratory distress due to pulmonary hypoplasia, particularly
in UT anomalies linked to oligohydramnios; and the presence
of a small thorax or a large pleural fluid collection possible in
ME CAs and hydrops respectively. Neonatal infections were
more common among fetuses with HGS or GI anomalies
because they usually require surgical treatments, blood vessel
catheterization for parenteral nutrition, blood transfusions,
and medications or fluid administration.
In summary, it was possible to identify several maternal
risk factors for CAs. High rates of adverse perinatal outcomes
were presented in all CA groups, and may differ according to
the type of CA considered.
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